News Hub | News Direct

Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
Article thumbnail News Release

Mental Health Provider Shortage Needs Integrated Approach

The Chicago School of Professional Psychology

One of two people who need mental health services don’t get it and more than one in three Americans live in a region where there are not enough mental health providers to serve the population.* The average wait time for a medical doctor’s appointment is up to 26 days, up 24 percent since 2004 and there is a projected shortage of 48,000 primary care physicians in the U.S. by 2034.+ “ At a time when the U.S. faces a severe shortage of mental health providers, many people are also finding it increasingly difficult to get the medical care they need,” said Dr. Michele Nealon, Psy.D., President of The Chicago School of Professional Psychology. “There is a way for society to address both these problems and that is to integrate the health care system so that primary care and mental health professionals work as a team to treat the whole person more efficiently and effectively,” she said. “We need to take a community-focused, patient-centered, and holistic view approach to mental and physical healthcare,” said Dr. Nealon explained. “Many physical ailments put us at risk for psychological disorders and vice versa, so it makes sense for mental health professionals to work closely with medical doctors to treat the patient when they initially present with symptoms, rather than waiting for a referral later.” “For example, if you have trouble sleeping or your child is experiencing frequent stomach aches, you might turn to your doctor for help. The problem may be physical, yet too often, there are psychological factors such as stress, anxiety or depression that are at play,” Dr. Nealon said. “At The Chicago School, we are always thinking about how to view humans as part of a larger system—how individuals relate to their family, culture and community,” she explained. “That’s why we are dedicated to educating culturally competent psychologists and counselors who get hands-on training in their communities.” The Chicago School of Professional Psychology’s seven campuses nationwide educates 6,000 students, 70 percent of whom identify as people of color. *Mental Health America https://mhanational.org/issues/state-mental-health-america +American Academy of Family Physicians https://www.aafp.org/pubs/fpm/blogs/inpractice/entry/wait-times.html About The Chicago School of Professional Psychology: Integrating theory with hands-on experience, The Chicago School of Professional Psychology provides education rooted in a commitment to innovation, service, and community for thousands of diverse students across the United States and globally. Founded in 1979, the nonprofit, regionally accredited university now features campuses in iconic locations across the country (Chicago, Southern California, Washington, D.C., New Orleans, Dallas) and online. To spark positive change in the world where it matters most, The Chicago School has continued to expand its educational offerings beyond the field of psychology to offer more than 30 degrees and certificates in the professional fields of health services, education, counseling, business, and more. Through its engaged professional model of education, commitment to diversity and inclusion, and an extensive network of domestic and international professional partnerships, The Chicago School’s students receive real-world training opportunities that reflect their future careers. The Chicago School is proud to be a part of TCS Education System, a nonprofit, integrated system of colleges and universities that works collaboratively to advance student success and community impact. To learn more, visit www.thechicagoschool.edu. Contact Details Vivien Hao +1 323-893-4743 vhao@thechicagoschool.edu

April 07, 2023 11:59 AM Pacific Daylight Time

Article thumbnail News Release

Chill Brands Group gives itself "really good growth capital" with latest fundraise

Chill Brands Group PLC

Chill Brands Group PLC (LSE:CHLL, OTCQB:CHBRF) CEO Callum Sommerton speaks to Proactive after announcing a £2.6mln fundraise that he says provides the company with "really good growth capital". Sommerton also talks about the company's expansion into nicotine-free vaping, something he sees as serious growth opportunity in a changing market. Contact Details UK Editorial +44 20 7989 0813 uk@proactiveinvestors.com

April 06, 2023 09:55 AM Eastern Daylight Time

Video
Article thumbnail News Release

Destiny Pharma upbeat on prospects for C. Difficile treatment

Destiny Pharma PLC

Destiny Pharma PLC (AIM:DEST, OTC:DTTYF) chief scientific officer Bill Love speaks to Proactive after results from a study into its C. Difficile treatment platform NTCD-M3 were published in the Microbiology Spectrum journal. Love explains what makes the platform so promising from Destiny's point of view, before going on to reveal more about the plans for bringing NTCD-M3 to the market. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

April 06, 2023 09:53 AM Eastern Daylight Time

Video
Article thumbnail News Release

Aqua Cultured Foods Closes $5.5M Seed Round led by Stray Dog Capital

AquaCultured Foods

Food tech startup Aqua Cultured Foods today announced it has raised $5.5 million in seed funding to bring its ultra-realistic seafood alternatives to market. The round was led by Stray Dog Capital, a venture capital fund specializing in alternative protein investments, with participation from H Venture Partners, Aztec Capital Management and Amplifica Capital, along with follow-on investment from current investors Supply Change Capital, Big Idea Ventures, HPA, Aera VC, Kingfisher Family Investments, and Swiss Pampa. The round also included a strategic investment from CJ CheilJedang, a South Korea-based global food and bio company owning renowned brands such as Bibigo. Aqua will use the investment to equip its new facility, scale up production, bring products to market, add key talent, and expand its roster of restaurant and foodservice outlets for product introductions this year. “We appreciate having mission-aligned partners that offer strong strategic value for the next phase of our growth, which will involve building up the business and brand,” said Anne Palermo, CEO of Aqua. “Being good stewards of investor capital is important to us, so along with hitting milestones earlier than expected, we are benefiting from government programs, academic resources, and other advantages to get to market quickly.” Aqua’s primary value is its low cost of scaling and its path to price parity, thanks to proprietary fermentation methods that use relatively affordable inputs and equipment. The company recently acquired a food-grade facility that was already built out nearly to its requirements—which it estimates will save more than a million dollars in construction costs. Aqua was recently accepted into the Illinois Office of Business Development’s EDGE program that provides tax incentives to growing companies, which will save hundreds of thousands of dollars in taxes over the next 10 years. “The adage is true that early-stage funds heavily weight investment conviction in people, and less in technologies or products given the embryonic nature of companies at these stages, but Aqua already boasts strength across its team, product, and key partnerships already in place,” said Johnny Ream, Partner at Stray Dog Capital. “We are interested in backing founding teams leveraging unique technologies and approaches that drive a more sustainable future; the work Aqua is doing with alt-seafood has immense potential to drive both human and planetary benefits in a massive $100B+ global market.” The global plant-based seafood market was valued at $42.1 million in 2021, and is projected to reach $1.3 billion by 2031 with a CAGR of more than 42 percent as wild fish stocks are further depleted. In addition to depleted fish populations, commercial fishing practices result in damage to ecosystems, plastic waste, and “bycatch” of non-target species. As fish farming increases, so does habitat destruction, pollution and diseases spread to wild fish, and the industry’s reliance on antibiotics and wild-caught fish for feed. Despite its health halo, fish contains microplastics, mercury, pesticides, antibiotics, dioxin and PCBs. High in cholesterol and saturated fats, seafood, in particular finfish, is a good source of foodborne illness caused by bacteria, viruses and parasites. Aqua is developing calamari, shrimp, scallops, and filets of tuna and whitefish with proprietary mycoprotein fermentation processes that do not use any animal inputs, genetic altering or modification. Unlike plant-based processed foods formulated with starches and protein isolates, Aqua’s alt-seafood retains its naturally occurring fiber, protein, and other micronutrients. The company also produces minced “seafood” fillings for applications such as dumplings, ravioli, and sushi rolls. For images visit https://app.box.com/s/wfbrvgraf2ty2b7by5h6ahjsaqrd8zx3. Follow Aqua Cultured Foods LinkedIn https://www.linkedin.com/company/aquacultured-foods Instagram https://www.instagram.com/aquaculturedfoods Facebook https://www.facebook.com/AquaCulturedFoods Twitter https://twitter.com/eatAquaFoods ‎ About Aqua Cultured Foods Aqua Cultured Foods is an innovative food technology startup developing the world’s first whole-muscle cut seafood alternatives created through microbial fermentation. Its novel technology produces a sustainable, complete protein source using only a fraction of the resources required by traditional aquaculture. As an R&D company with a focus on product commercialization, Aqua Cultured Foods occupies a unique position in the burgeoning alt-seafood market as well as within the fermentation industry. The company’s mission is to mitigate global challenges such as overfishing, climate change and feeding the world’s expanding population with delicious, nutrient-rich foods. For more information visit https://www.aquaculturedfoods.com. About Stray Dog Capital Stray Dog Capital is a venture capital fund investing in innovative, early-stage companies across the food, beverage, and biotechnology sectors that are driving a healthier, humane, and more sustainable future. Stray Dog Capital supports its portfolio of investments with broad experience from its team as entrepreneurs, operators, advisors, and investors. www.straydogcapital.com. ### Contact Details Gary Smith +1 818-783-0569 gary@evolotuspr.com Company Website https://www.aquaculturedfoods.com

April 06, 2023 09:05 AM Eastern Daylight Time

Image
Article thumbnail News Release

Futura Medical "confident of getting FDA approval this quarter"

Futura Medical PLC

Futura Medical PLC (AIM:FUM, OTC:FAMDF) CEO James Barder speaks to Proactive following the release of full year results for 2022. Barder says that despite losses, revenues "are now rapidly coming over the horizon" and he suggests "the last two years have been very very good for us". He adds that he's "confident of getting FDA approval for MED3000 this quarter" Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

April 06, 2023 06:12 AM Eastern Daylight Time

Video
Article thumbnail News Release

Faron Pharmaceuticals moving "into next phase" with new CFO

Faron Pharmaceuticals Oy

Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) chief financial officer James O'Brien speaks to Proactive on his second day in the new role. O'Brien reveals more about what he believes he can bring to Faron, highlighting his experience in the US capital markets. He adds that Faron is now moving "into [its} next phase of growth." Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

April 06, 2023 05:27 AM Eastern Daylight Time

Video
Article thumbnail News Release

MGC Pharmaceuticals' focus "will not change" despite psilocybin news

MGC Pharmaceuticals Ltd

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) chief commercial officer Robert Clements speaks to Proactive after announcing that the company has been granted permission by the Slovenian government to conduct research into psilocybin, a naturally occurring psychedelic compound found in certain types of mushrooms. The company will work in partnership with other pharmaceutical companies to determine the best potential use for psilocybin. Clements says that "the focus of MGC will not change" despite the news, adding that it is fully committed to its current pipeline of products. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

April 06, 2023 05:14 AM Eastern Daylight Time

Video
Article thumbnail News Release

Xeris Biopharma enters research collaboration with Regeneron Pharmaceuticals to advance XeriJect

Xeris Biopharma Holdings

Xeris Biopharma chairman and CEO Paul Edick joins Proactive's Natalie Stoberman to share details behind its research evaluation collaboration with Regeneron Pharmaceuticals for further XeriJect development. Edick says the agreement will see Xeris using its proprietary drug-formulation platform, XeriJect, to develop ultra-highly concentrated, ready-to-use, small volume subcutaneous injections of two undisclosed monoclonal antibodies developed by Regeneron. Xeris will receive an upfront payment and potential milestone payments for preclinical achievements. Regeneron will have an option to commercially license the Xeris technology for such molecules and nominate additional molecules for reformulation and potential commercialization. Contact Details Proactive Investors +1 347-449-0879 na-editorial@proactiveinvestors.com

April 05, 2023 01:18 PM Eastern Daylight Time

Video
Article thumbnail News Release

HealthLynked discusses year-end financials and MedOfficeDirect prospects in development

HealthLynked

HealthLynked chairman and CEO Dr Michael Dent and chief financial officer George O'Leary join Proactive's Natalie Stoberman to share highlights from the company's fourth-quarter and full-year 2022 financial results. HealthLynked reported revenue of $5.86 million, a 10% decrease compared to $6.50 million in 2021. Dent says the decline is primarily attributed to decreases in patient service revenue at the Naples Women’s Center and Bridging the Gap facilities, as well as lower product revenue from MedOfficeDirect. However, the company has reported that the decrease was partially offset by revenue increases at its Naples Center for Functional Medicine facility and revenue from the newly-acquired Aesthetics Enhancements Unlimited practice. Contact Details Proactive Investors +1 347-449-0879 na-editorial@proactiveinvestors.com

April 05, 2023 01:13 PM Eastern Daylight Time

Video
1 ... 120121122123124 ... 285